• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.
    Pelabresib
    |
    Weekly News Recap #Phispers Pelabresib
    FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

    FTC disputes relevance of over 300 patent listings; Japan’s Ono to buy Deciphera for US$ 2.4 bn

    The price of drugs is the highest in the US, and the White House has been working on bringing down drug prices for several year...

    Impressions : 1330

    Novo’s parent buys Catalent for US$ 16.5 bn, Lilly calls for scrutiny; Novartis acquires MorphoSys

    Novo’s parent buys Catalent for US$ 16.5 bn, Lilly calls for scrutiny; Novartis acquires MorphoSys

    The Novo Nordisk-Eli Lilly rivalry over obesity drugs got intensified with Novo Nordisk’s parent company acquiring contra...

    Impressions : 1523

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.